Sessa Francesco, Bertozzi Giuseppe, Cipolloni Luigi, Baldari Benedetta, Cantatore Santina, D'Errico Stefano, Di Mizio Giulio, Asmundo Alessio, Castorina Sergio, Salerno Monica, Pomara Cristoforo
Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy.
Department of Anatomical, Histological, Forensic and Orthopedic Sciences, Sapienza University of Rome, 00186 Rome, Italy.
J Clin Med. 2020 Jun 28;9(7):2026. doi: 10.3390/jcm9072026.
The severe acute respiratory syndrome (SARS)-CoV-2 was identified for the first time in China, in December 2019. Confirmed cases of COVID-19 have been reported around the world; indeed, this infection has been declared a pandemic. Consequently, the scientific community is working hard to gain useful information about the history of this virus, its transmission, diagnosis, clinical features, radiological findings, research and development of candidate therapeutics as well as vaccines. This review aims to analyze the diagnostic techniques used to ascertain the COVID-19 infection, critically reviewing positive points and criticism for forensic implications, obviously including autopsy. Finally, this review proposes a practical workflow to be applied in the management of corpses during this outbreak of the COVID-19 infection, which could be useful in cases of future infectious disease emergencies. Analyzing the diagnostic methods, to date, virus nucleic acid RT-PCR represents the standard method used to ascertain the COVID-19 infection in living subjects and corpses, even if this technique has several criticisms: mainly, the staff should be highly specialized, working in high-throughput settings, able to handle high workloads and aware of health risks and the importance of the results. Thus, IgG/IgM serological tests have been developed, overcoming RT-qPCR duration, costs, and management, not requiring highly trained personnel. Nevertheless, serological tests present problems; the WHO recommends the use of these new point-of-care immunodiagnostic tests only in research settings. Furthermore, nothing has yet been published regarding the possibility of applying these methods during post-mortem investigations. In light of this scenario, in this review, we suggest a flow chart for the pathologist called on to ascertain the cause of death of a subject with historical and clinical findings of COVID-19 status or without any anamnestic, diagnostic, or exposure information. Indeed, the literature data confirmed the analytical vulnerabilities of the kits used for laboratory diagnosis of COVID-19, particularly during postmortem examinations. For these reasons, autopsy remains the gold standard method to ascertain the exact cause of death (from or with COVID-19 infection, or other causes), to consequently provide real data for statistical evaluations and to take necessary measures to contain the risks of the infection. Moreover, performing autopsies could provide information on the pathogenesis of the COVID-19 infection with obvious therapeutic implications.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)于2019年12月在中国首次被发现。全球范围内已报告了新型冠状病毒肺炎(COVID-19)确诊病例;事实上,这种感染已被宣布为大流行。因此,科学界正在努力获取有关这种病毒的历史、传播、诊断、临床特征、影像学表现、候选治疗方法以及疫苗研发等方面的有用信息。本综述旨在分析用于确定COVID-19感染的诊断技术,批判性地审视其优点以及对法医应用(显然包括尸检)的批评意见。最后,本综述提出了一种在COVID-19感染爆发期间应用于尸体管理的实用工作流程,这在未来传染病紧急情况中可能会有用。分析诊断方法可知,迄今为止,病毒核酸逆转录聚合酶链反应(RT-PCR)是用于确定活体和尸体中COVID-19感染的标准方法,即便该技术存在一些批评意见:主要是工作人员应高度专业化,在高通量环境中工作,能够处理高工作量,并意识到健康风险以及结果的重要性。因此,已经开发了IgG/IgM血清学检测方法,克服了RT-qPCR的耗时、成本和管理问题,且不需要训练有素的人员。然而,血清学检测也存在问题;世界卫生组织建议仅在研究环境中使用这些新的即时免疫诊断检测方法。此外,关于在尸检调查中应用这些方法的可能性尚未有任何发表的内容。鉴于这种情况,在本综述中,我们为被要求确定具有COVID-19状态的历史和临床发现或无任何既往史、诊断或暴露信息的受试者死因的病理学家建议了一个流程图。的确,文献数据证实了用于COVID-19实验室诊断的试剂盒在分析方面的脆弱性,尤其是在尸检期间。出于这些原因,尸检仍然是确定确切死因(因COVID-19感染或伴有COVID-19感染,或其他原因)的金标准方法,从而为统计评估提供真实数据,并采取必要措施控制感染风险。此外,进行尸检可以提供有关COVID-19感染发病机制的信息,具有明显的治疗意义。